期刊
DALTON TRANSACTIONS
卷 46, 期 33, 页码 10758-10773出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c7dt01955f
关键词
-
资金
- Canadian Cancer Society Research Institute [702491]
Although copper-ligand complexes appear to be promising as a new class of therapeutics, other than the family of copper(II) coordination compounds referred to as casiopeinas these compounds have yet to reach the clinic for human use. The pharmaceutical challenges associated with developing copper-based therapeutics will be presented in this article along with a discussion of the potential for high-throughput chemistry, computer-aided drug design, and nanotechnology to address the development of this important class of drug candidates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据